Register Now

Overview

The landscape of type 2 diabetes and obesity management has shifted with novel incretin-based therapies. Get your important updates in diabetes and obesity management during this 45-minute course. Learn how to optimize diabetes control, weight management, cardiovascular and renal protection for your patients while minimizing potential side-effects.

Learning Objectives

  • Counsel patients on management plans that simultaneously address diabetes control, weight management, and cardiovascular and renal protection
  • Differentiate between first- and second-generation GLP-1 receptor agonists and dual/triple co-agonists (such as tirzepatide or retatrutide) regarding their weight-loss efficacy, metabolic impact, and side-effect profiles